In Subjects Who Received SAT with DAL
1 clinical trials · Condition
◉ Watch In Subjects Who Received SAT with DAL
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Dalbavancin As Suppressive Therapy (NCT06899906) | Hospices Civils de Lyon | 2024-10-01 |
Track In Subjects Who Received SAT with DAL automatically
Every clearance here is in the API, with alerts when new ones post.